chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 12 month old male who on 4, Nov 2006 was vaccinated subcutaenously in the left arm with a first dose of measles virus vaccine (+) mumps virus vaccine (+) rubella virus vaccine (RA 27/3) (+) varicella virus vaccine (Oka/Merck upgrade process) (lot# 655141/0833F). Eleven days following the vaccination, on 15, Nov 2006, the patient developed a rash. The rash developed into erythema multiforme and required a visit to the ER and an extra office visit. It was reported that the patient was also on an antibiotic for an ear infection. Subsequently. the patient recovered from erythema multiforme on an unspecified date. Additional information is not expected.
sz activity noted by mom; arched back shaking extremities pursing lips; lasted 3-5 mins; t99 R;
pt cried incessantly for 5 hrs p/vax was given; cry was strong & of nl pitch; no fever pt had mild local reaction (3x3 cm erythema & swelling);
arm was so sore; arm was so sore and she could hardly move it; the first dose two years ago / never received the second dose; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu unspecified (Influenza vaccine) for prophylaxis, PNEUMOCOCCAL VACCINE (PNEUMONIA SHOT) for prophylaxis and Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix, Influenza vaccine, PNEUMONIA SHOT and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and Influenza vaccine and not applicable after receiving Shingrix, the patient experienced pain in arm, mobility decreased and incomplete course of vaccination. On an unknown date, the outcome of the pain in arm and mobility decreased were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the pain in arm and mobility decreased to be related to Shingrix and Influenza vaccine.  Additional information was provided as follows: The patient reported that no one told her she needed two doses of the Shingrix vaccine. She received the first dose two years before reporting and never received the second dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. On the same day of receiving Shingrix, she also received the second dose of the pneumonia vaccine and a flu vaccine. She claimed that after getting her Shingrix vaccine, her arm was so sore and she could hardly move it. The side effects lasted a couple of weeks. They gave her the shot in her left arm in the back of her arm. It was unknown if the reporter considered the pain in arm and mobility decreased to be related to pneumonia shot. The reporter consented to follow up.
Blister rash on top left wrist; red raised bumps in index and thumb; This is a spontaneous report from a contactable consumer or other non hcp reported for herself. A 54-years-old non-pregnant female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: not reported), via an unspecified route of administration, administered in Arm Left on 15May2021 at 10:00 as 1st dose, single for covid-19 immunisation. Medical history included asthma and rubber sensitivity (known allergies: Latex tape) from an unknown date and unknown if ongoing. Concomitant medication(s) included Singular, Dupixent and Claritin (the patient received within 2 weeks of vaccination). On 19May2021, the patient experienced blister rash on top left wrist; red raised bumps in index and thumb. Patient did not receive any treatment. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 15May2021 Nasal Swab. The outcome of both events was not recovered.  Information on the lot/batch number has been requested.
MISSED TO TAKE LAST DOSE; This spontaneous case (PVX2019-1130) was received from a pharmacist on 07-May-2019. It describes a 27-year-old female consumer who "missed to take last dose", while being on Vivotif for travelling.  Case report: The consumer took three doses of Vivotif in Dec 2018. She missed to take the last dose.  Action taken with Vivotif was not applicable.  The clinical outcome of the event "missed to take last dose" was unknown.  Company's Comment: The causality of the event "missed to take last dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take last dose" was considered as not applicable.
Pt reported swollen tongue with blisters, sore throat, cough. Pt took Benadryl and symptoms resolved.
Joint aches, body aches, head ache, fever. Extreme dizziness and blurry vision, fainting.
Severe headache and body soreness, 102 fever with using OTC , left arm rash with pain and itching.
pt recv vax 8NOV95 & 8MAR97 pt devel fluid-filled, vesicular lesions on chest, leg, back, & buttocks;
THROAT PAIN; PAIN; RUNNY NOSE; COUGH; HEADACHE; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient has no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced throat pain. On 09-APR-2021, the subject experienced pain. On 09-APR-2021, the subject experienced runny nose. On 09-APR-2021, the subject experienced cough. On 09-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from cough, and had not recovered from headache, runny nose, pain, and throat pain. This report was non-serious.
usually got sick with any virus that was out there; Initial information received on 10-Dec-2020 regarding this unsolicited valid non-serious social media case from a consumer (patients wife) via social media.  This case involved a male patient of unknown age who usually got sick with any virus that was out there (illness), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination every year.  On an unknown date, the patient usually got sick with any virus that was out there (illness) (Unknown latency) following the administration of INFLUENZA VACCINE. The patient got viruses and got the flu shot.  Details of laboratory data was not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown for the event, at the time of reporting.  There will be no information available on the batch number for this case.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
hives over left ext and upper body, hives resolved in a few days, itching remains 7 days later
24 hours after the injection patient noticed a red wheal approximately 1" in diameter. It was itching and burning. The rash increased in size to 3 1/2-2 3/4 inches in diameter. 72 hours after injection the rash was 1"x 2". Patient put 1 application of NEOSPORIN on rash.
About 3 minutes after I had left eye pain - like something was in my eye. Ignored it. My blood vessel in left eye was also enlarged, I noticed later. Eye doctor to the next day: she said she sees it in virus infected people. She took a picture of the inside of my eyeball. Told me to Treat with Tylenol, put ice on it and wait to see. It was about four days after vaccine everything resolved.  I had the second dose  Today around 7:00 am  and it came back - around 12:30 PM - pain and enlarged blood vessel. I do have a lazy eye in the left eye that I was born with.
Information has been received from a Licensed Practical Nurse concerning a 26 week old patient who on 22-APR-2009 was vaccinated with the first dose of ROTATEQ.  On 17-AUG-2009 the patient was vaccinated with the second dose of ROTATEQ.  The patient did not receive a third dose.  No adverse effect was reported.
At 4:15 am on the 25th, she became severly ill, including low blood pressure, and sweating profusley, uncontrollable diahrea and severe abdominal pain, and then within 2 hours, she had 2 seizures, went into cardiac arrest and was pronounced dead at 6:29am.
This spontaneous report as received from a nurse refers to a patient of unknown age. The nurse reported patient received dose of (unspecified) (Merck) VARIVAX (0.5 ml once, Subcutaneous, lot # J003534, exp 25-MAR-2015) that was stored at 10F for 264 hours. Nurse reported patient had (Merck) VARIVAX administered for an unspecified time in the last 2 weeks (between 03-NOV-2014 and 14-NOV-2014). No adverse effects reported. Additional information has been requested.
Approximately 6 hours after receiving vaccine, patient had left side chest pain for 2 weeks. She did not seek treatment, she did not take any medication for pain, she was not evaluated by a physician.
This spontaneous report as received from a registered nurse refers to a 15 month old patient. On 10-SEP-2013, the patient was inadvertently vaccinated with a dose of 0.5 ml PROQUAD, (lot number, expiry date was not reported and route was subcutaneous) and other suspect therapies included VARIVAX (Merck) (lot number, expiry date and route was not reported) at the same time. No adverse events were reported. Additional information has been requested.
This spontaneous report as received from a consumer via Clinic refers to a currently 14 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 08-JUN-2017, the patient was vaccinated with improperly stored dose of M-M-R II, recombinant human albumin (rHA) 1 dose unit ( lot # M008589, Expiry date was not reported) for prophylaxis. There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-1801USA000166:
It was not an adverse event, but an administration error. The 8 year old was given the adult concentration and dose.
Gastroenteritis  Dehydration  Nausea  Diarrhea, unspecified type  Essential hypertension  Other headache syndrome  Hyperkalemia
One of twenty-one cases:  A non - serious, spontaneous event of a half dose of FLUMIST administered was received from a registered nurse.  The event occurred in an eighth grade, adolescent female.  No medical or drug history was reported for this adolescent.  FLUMIST was inadvertently administered in one nostril to 21 children during the flu clinic at an elementary school.  The nurse administering the doses had been trained on administering FLUMIST but forgot to take off the divider clip;  21 children received only half a dose.  No adverse effects were reported; the event is considered resolved.
Female patient received her covid-19 Janssen and approximately less than 10 minutes after, she had a panic episode. She fell off of her chair onto her left shoulder. Pharmacist was there immediately trying to assist her. Her eyes were open but patient was unresponsive. Approximately, 10-15 seconds later she came back to it and tried to get up. I asked her to stay down and relax. patient was asked if she was aware of where she was and time and she responded properly. Then she mentioned she has had panic attacks previously. Emergency services was notified immediately and Market director.  Patients vitals were taken and her blood pressure started at 135/95 mmHg 85 hr. 5 minutes later her vitals were done to 127/87 mmHg 82 hr.  By the time, emergency services arrived she was sitting done on her chair and feeling much better. She refused Emergency services. She sat in the observation room for 20 minutes after and was checked on by the pharmacist. She was stable and in good spirit when she left.
Arm was swollen and itchy/Larger swelling, more itching; Throbbing; Overall weakness of arm; larger swelling, more itching, throbbing; larger swelling, more itching, throbbing; Overall weakness of my arm; larger swelling, more itching, throbbing; Arm was swollen and itchy; FELT LIKE BEE STING; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Arm was swollen and itchy), ARTHROPOD STING (FELT LIKE BEE STING), VACCINATION SITE PRURITUS (Arm was swollen and itchy/Larger swelling, more itching), VACCINATION SITE PAIN (Throbbing) and ASTHENIA (Overall weakness of arm) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Arm was swollen and itchy) and ARTHROPOD STING (FELT LIKE BEE STING). On 19-Jan-2021, the patient experienced SWELLING (larger swelling, more itching, throbbing), PAIN (larger swelling, more itching, throbbing) and MUSCULAR WEAKNESS (Overall weakness of my arm). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Arm was swollen and itchy/Larger swelling, more itching), VACCINATION SITE PAIN (Throbbing), ASTHENIA (Overall weakness of arm) and PRURITUS (larger swelling, more itching, throbbing). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 18-Jan-2021 at an unspecified dose and frequency; PREDNISONE ongoing from 20-Jan-2021 at a dose of 20 milligram twice a day and AMOXICILLIN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Arm was swollen and itchy), ARTHROPOD STING (FELT LIKE BEE STING), VACCINATION SITE PRURITUS (Arm was swollen and itchy/Larger swelling, more itching), VACCINATION SITE PAIN (Throbbing), ASTHENIA (Overall weakness of arm), SWELLING (larger swelling, more itching, throbbing), PRURITUS (larger swelling, more itching, throbbing), PAIN (larger swelling, more itching, throbbing) and MUSCULAR WEAKNESS (Overall weakness of my arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Little bit of soreness in his right arm he felt the soreness in his left arm/when you touch the spot it was a little sore; Little tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little bit of soreness in his right arm he felt the soreness in his left arm/when you touch the spot it was a little sore) and VACCINATION SITE PAIN (Little tenderness) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (Little bit of soreness in his right arm he felt the soreness in his left arm/when you touch the spot it was a little sore) and VACCINATION SITE PAIN (Little tenderness). On 09-Jan-2021, PAIN IN EXTREMITY (Little bit of soreness in his right arm he felt the soreness in his left arm/when you touch the spot it was a little sore) and VACCINATION SITE PAIN (Little tenderness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment medication was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Stuffy nose; Loss of taste; headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Apr2021 at 15:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included vitamin D, ascorbic acid (VITAMIN C) and synthetic prenatal vitamin. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received Ibuprofen and experienced allergy. The patient also previously received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 at 15:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01May2021 at 13:00, the patient experienced stuffy nose, loss of taste, headache and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcomes of the events stuffy nose, loss of taste, headache and fatigue were not resolved.   No follow-up attempts are needed; information about lot number cannot be obtained.
Chills and fever up to 102 at 9:00am on 02/06/2021. Low grade fever of 99 -100 for most of the day. Took ibuprofen x2 that date. Temperature was. 97.8 at 10:00am on 02/07/2021.
PAIN IN MY BACK CRAWLING TO MY LOWER  BACK; PAIN IN MY SHOULDER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26. cov2. s (dose number in series 1, unspecified manufacturer) (suspension for injection, route of admin, and batch number were not reported) dose not reported, 1 total, start therapy date were not reported for prophylactic vaccination. It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s  (dose number in series 2) (suspension for injection, route of admin and batch number were not reported) dose not reported, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, after receiving booster vaccine the patient had too much pain in shoulder and in back crawling to lower back (dose number in series 2 adverse event). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain in shoulder and pain in back was not reported. This report was non-serious.
Hospitalization/Death due to COVID-19 Reported per Pfizer COIVID-19 Vaccine EUA
Dizzy, headache, N&V, sore throat, fever 101, achy muscles, no energy times 2 days.
Arm felt heavy, site swollen, harden and warm to touch on the vaccinated area.
Information has been received from a female patient, who in February 2008, was vaccinated with a dose of ZOSTAVAX vaccine (Oka/Merck) (Lot. # unspecified). In 2008, the patient had developed shingles on a side of her face. It is unknown if the patient sought medical attention. At the time of reporting (02-DEC-2008) the outcome of the patient was not recovered. Additional information has been requested. Follow up information has been received from a completed Herpes Zoster questionnaire, from a physician concerning a female patient with a history of chickenpox in her childhood, who in January 2008, was vaccinated with a dose of ZOSTAVAX vaccine (Oka/Merck). In December 2008, the patient developed shingles on the right trigeminal. The patient also developed iritis and scleritis quantifying the pain as 5 from 0 to 10 (Most) (December 2008). On an unspecified date the patient recovered (200*0. The physician also stated that the ZOSTAVAX vaccine (Oka/Merck) was not administered in his clinic. Additional information is not expected.  Following information has been received from a completed Herpes Zoster questionnaire, from a physician concerning a female patient with history of chickenpox in her childhood, who in January 2008, was vaccinated with a dose of ZOSTAVX. In December 2008, the patient developed shingles on the right trigeminal. The patient also developed laities and sclerosis quantifying the pain as 5 form 0 to 10(December 2008). On an unspecified date the patient recovered (2008). The physician also stated that the ZOSTAVAX was not administered in his clinic. Additional information has been received on 20-MAR-2009 from the 74 year old health female patient, who on 09-JUK-2008 received a dose of ZOSTAVAX (lot not reported). On 29-NOV-2009 the patient developed shingles. The reporter stated that she was still being treated by her "eye doctor" because she might loose her eye sight; the patient also stated that she had suffered so much pain over two months. Additional information is not expected.
4/1/2022 thru 04/07/2022 and ongoing:  Trouble beathing, severe pain in coastal ribs, excessive and painful belching/burping